University Medical Center Groningen: Kidney Diseases trials

The registry lists 11 Kidney Diseases studies with University Medical Center Groningen as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 2 1Phase 3 2Phase 4 3No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next GenerationRecruitingNCT07291258
• FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system InhibitorsEnrolling by invitationNCT07181135Phase 3
• Method VALIDation and Evaluation of Non-radioactive Methods to Measure Glomerular Filtration RateNot yet recruitingNCT06259422Not applicable
• Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.CompletedNCT06374043Phase 4
• Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated AlbuminuriaCompletedNCT05570305Phase 2
• RECOVAC Repeated Vaccination StudyCompletedNCT05030974Phase 4
• RECOVAC - Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease PatientsCompletedNCT04841785
• The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) StudyCompletedNCT04741386
• SodiUm Burden Lowered by Lifestyle Intervention: Self-Management and E-health TechnologyCompletedNCT02132013Not applicable
• Study of Lanreotide to Treat Polycystic Kidney DiseaseStatus unknownNCT01616927Phase 3
• Benfotiamine in Diabetic NephropathyCompletedNCT00565318Phase 4